AAAAAA
Results:
1-21
|
Results: 21
Authors:
Gilbert, R
Dunn, D
Wallon, M
Hayde, M
Prusa, A
Lebech, M
Kortbeek, T
Peyron, F
Pollak, A
Petersen, E
Citation: R. Gilbert et al., Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol, EPIDEM INFE, 127(1), 2001, pp. 113-120
Authors:
Jaisson-Hot, I
Wallon, M
Al Kurdi, M
Thulliez, P
Kahi, S
Cozon, G
Peyron, F
Citation: I. Jaisson-hot et al., Transient negative serology in congenital toxoplasmosis, PRESSE MED, 30(20), 2001, pp. 1001-1004
Authors:
Wallon, M
Cozon, G
Ecochard, R
Lewin, P
Peyron, F
Citation: M. Wallon et al., Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children, EUR J PED, 160(9), 2001, pp. 534-540
Authors:
Peyron, F
Favel, A
Michel-Nguyen, A
Gilly, M
Regli, P
Bolmstrom, A
Citation: F. Peyron et al., Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest, J CLIN MICR, 39(1), 2001, pp. 339-342
Authors:
Romand, S
Wallon, M
Franck, J
Thulliez, P
Peyron, F
Dumon, H
Citation: S. Romand et al., Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis, OBSTET GYN, 97(2), 2001, pp. 296-300
Authors:
Gherardi, A
Sarciron, ME
Peyron, F
Citation: A. Gherardi et al., Toxoplasma encephalitis: Influence of the vehicle on the efficacy of different doses of 2 ',3 '-dideoxyinosine in mice, PARASITE, 7(1), 2000, pp. 39-42
Authors:
Contini, C
Fainardi, E
Cultrera, R
Seraceni, S
Castellazzi, M
Peyron, F
Granieri, E
Citation: C. Contini et al., Evidence of cerebrospinal fluid free kappa light chains in AIDS patients with Toxoplasma gondii encephalitis, J NEUROIMM, 108(1-2), 2000, pp. 221-226
Authors:
Sarciron, ME
Saccharin, C
Petavy, AF
Peyron, F
Citation: Me. Sarciron et al., Effects of artesunate, dihydroartemisinin, and an artesunate-dihydroartemisinin combination against Toxoplasma gondii, AM J TROP M, 62(1), 2000, pp. 73-76
Authors:
Wallon, M
Liou, C
Garner, P
Peyron, F
Citation: M. Wallon et al., Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy, BR MED J, 318(7197), 1999, pp. 1511-1514
Authors:
Kahi, S
Cozon, GJN
Peyron, F
Citation: S. Kahi et al., Early detection of cellular immunity in congenitally Toxoplasma gondii-infected children, PEDIAT INF, 18(9), 1999, pp. 846-847
Authors:
Peyron, F
Citation: F. Peyron, Parasitologic diagnosis of malaria: routine and new laboratory techniques, MED MAL INF, 29, 1999, pp. 295S-301S
Authors:
Wallon, M
Dunn, D
Slimani, D
Girault, V
Gay-Andrieu, F
Peyron, F
Citation: M. Wallon et al., Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA?, EUR J PED, 158(8), 1999, pp. 645-649
Authors:
Favel, A
Peyron, F
De Meo, M
Michel-Nguyen, A
Carriere, J
Chastin, C
Regli, P
Citation: A. Favel et al., Amphotericin B susceptibility testing of Candida lusitaniae isolates by flow cytofluorometry: comparison with the Etest and the NCCLS broth macrodilution method, J ANTIMICRO, 43(2), 1999, pp. 227-232
Authors:
Cozon, GJN
Ferrandiz, J
Thulliez, P
Peyron, F
Citation: Gjn. Cozon et al., Flow cytometric application of the Sabin and Feldman dye test in the diagnosis of toxoplasmosis, J MICROB M, 38(1-2), 1999, pp. 131-136
Authors:
Dunn, D
Wallon, M
Peyron, F
Petersen, E
Peckham, C
Gilbert, R
Citation: D. Dunn et al., Mother-to-child transmission of toxoplasmosis: risk estimates for clinicalcounselling, LANCET, 353(9167), 1999, pp. 1829-1833
Authors:
Gherardi, A
Sarciron, ME
Petavy, AF
Peyron, F
Citation: A. Gherardi et al., Purine pathway enzymes in a cyst forming strain of Toxoplasma gondii, LIFE SCI, 65(17), 1999, pp. 1733-1738
Authors:
Gay-Andrieu, F
Cozon, GJN
Ferrandiz, J
Kahi, S
Peyron, F
Citation: F. Gay-andrieu et al., Flow cytometric quantification of Toxoplasma gondii cellular infection andreplication, J PARASITOL, 85(3), 1999, pp. 545-549
Authors:
Kahi, S
Cozon, GJN
Pinon, JM
Greenland, T
Wallon, M
Al Kurdi, M
Ferrandiz, J
Peyron, F
Citation: S. Kahi et al., A switch towards Th2 during serological rebound in children with congenital toxoplasmosis, CLIN EXP IM, 117(3), 1999, pp. 524-528
Authors:
Sarciron, ME
Walchshofer, N
Paris, J
Petavy, AF
Peyron, F
Citation: Me. Sarciron et al., Phenylalanine derivatives active against Toxoplasma gondii brain cysts in mice, PARASITE, 5(4), 1998, pp. 359-364
Authors:
Borel, E
Mayencon, M
Kaiser, K
Picot, S
Peyron, F
Citation: E. Borel et al., Fluorogenic detection of viable Toxoplasma gondii, PARASITE, 5(4), 1998, pp. 371-373
Authors:
Contini, C
Fainardi, E
Cultrera, R
Canipari, R
Peyron, F
Delia, S
Paolino, E
Granieri, E
Citation: C. Contini et al., Advanced laboratory techniques for diagnosing Toxoplasma gondii encephalitis in AIDS patients: significance of intrathecal production and comparison with PCR and ECL-western blotting, J NEUROIMM, 92(1-2), 1998, pp. 29-37
Risultati:
1-21
|